Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA postpones key hearing on biosimilar copy of blockbuster drug
FDA postpones key hearing on biosimilar copy of blockbuster drug
FDA postpones key hearing on biosimilar copy of blockbuster drug
Submitted by
admin
on February 26, 2015 - 9:55am
Source:
Yahoo/Reuters
News Tags:
FDA
biosimilars
Rensima
Remicade
JNJ
rheumatoid arthritis
Crohn's Disease
Hospira
Celltrion
Headline:
FDA postpones key hearing on biosimilar copy of blockbuster drug
Do Not Allow Advertisers to Use My Personal information
